betamethasone sodium phosphate has been researched along with Ocular Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamura, M; Zako, M | 1 |
| Gosho, M; Inaguma, S; Isogai, Z; Murasawa, Y; Yamada, H; Yoneda, M; Zako, M | 1 |
| Bucolo, C; Drago, F; Leggio, GM; Potenza, M; Privitera, MG | 1 |
3 other study(ies) available for betamethasone sodium phosphate and Ocular Hypertension
| Article | Year |
|---|---|
Long-term stability of uveitis with faint anterior chamber flare treated with once-daily topical ophthalmic betamethasone.
Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Aged, 80 and over; Anterior Chamber; Anti-Inflammatory Agents; Betamethasone; Child; Drug Administration Schedule; Female; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Uveitis, Anterior; Young Adult | 2014 |
A Rho-Associated Kinase Inhibitor Protects Permeability in a Cell Culture Model of Ocular Disease, and Reduces Aqueous Flare in Anterior Uveitis.
Topics: Adult; Aged; Aqueous Humor; Betamethasone; Cell Culture Techniques; Cell Membrane Permeability; Cells, Cultured; Female; Glaucoma; Humans; Isoquinolines; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Protein Kinase Inhibitors; Retrospective Studies; rho-Associated Kinases; Sulfonamides; Uveitis, Anterior | 2017 |
Hemin, an inducer of heme oxygenase-1, lowers intraocular pressure in rabbits.
Topics: Analysis of Variance; Animals; Betamethasone; Chymotrypsin; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Induction; Heme Oxygenase-1; Hemin; Injections, Intravenous; Intraocular Pressure; Male; Ocular Hypertension; Protoporphyrins; Rabbits; Random Allocation | 2007 |